Literature DB >> 3416236

Effects of sucralfate on gastric prostaglandin and leukotriene synthesis: relationship to protective actions.

J L Wallace1, G P Morris, P L Beck, T E Williamson, G R Gingras.   

Abstract

The mechanism of the protective actions of sucralfate against ethanol-induced gastric mucosal damage in the rat has been investigated. In particular, the role of prostaglandins as mediators of such protection was assessed. Oral administration of sucralfate at a dose causing a significant reduction of ethanol-induced gastric damage (500 mg/kg) did not significantly alter gastric 6-ketoprostaglandin F1 alpha synthesis. Pretreatment with indomethacin at a dose that inhibited gastric cyclooxygenase activity by an average of 88% did not affect the protective actions of sucralfate. To further investigate the mechanism of action of sucralfate, an ex vivo gastric chamber model was used in which sucralfate could be applied to only one side of the mucosa. Sucralfate did not affect gastric prostaglandin synthesis, but did cause a significant increase in leukotriene C4 synthesis, a fall in transmucosal potential difference, and a significant decrease in gastric myeloperoxidase activity on the side exposed to sucralfate. These observations suggest that sucralfate has an irritant action on the mucosa. The release of mediators in response to such irritation may play an important role in the protective action of sucralfate. The present study supports the hypothesis that prostaglandins do not mediate the protection afforded by exposure to sucralfate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3416236     DOI: 10.1139/y88-105

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  8 in total

1.  Effect of long-term sucralfate ingestion on antral and fundic epithelial proliferation in the rat.

Authors:  H Kuwayama
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

2.  Possible mechanism of increase in gastric mucosal PGE2 and PGI2 generation induced by ecabet sodium, a novel gastroprotective agent.

Authors:  M Kinoshita; H Tamaki
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

3.  Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats.

Authors:  Aline A da Cunha; Andréa G K Ferreira; Samanta O Loureiro; Maira J da Cunha; Felipe Schmitz; Carlos Alexandre Netto; Angela T S Wyse
Journal:  Neurochem Res       Date:  2012-04-08       Impact factor: 3.996

4.  Atorvastatin inhibits inflammatory hypernociception.

Authors:  T Santodomingo-Garzón; T M Cunha; W A Verri; D A R Valério; C A Parada; S Poole; S H Ferreira; F Q Cunha
Journal:  Br J Pharmacol       Date:  2006-07-24       Impact factor: 8.739

5.  Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats.

Authors:  A Kleine; S Kluge; B M Peskar
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

6.  EFFICACY OF SUCRALFATE IN PREVENTING GASTROINTESTINAL SIDE EFFECTS OF NSAIDs.

Authors:  A C Anand; C M Adya; S K Dham
Journal:  Med J Armed Forces India       Date:  2017-06-27

7.  Acid suppression therapy and allergic reactions.

Authors:  Eva Untersmayr
Journal:  Allergo J Int       Date:  2015-12

8.  IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin.

Authors:  Waldiceu A Verri; Thiago M Cunha; Carlos A Parada; Xiao-qing Wei; Sérgio Henrique Ferreira; Foo Y Liew; Fernando Q Cunha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.